In contrast to HER1 and HER2, our study on bladder tumours (Memon et al, 2004) and other studies on breast tumours (Abd El-Rehim et al, 2004) have suggested that increased expression of HER3 and HER4 is associated with improved survival. Here, ERBB2 is linked to urinary bladder neoplasm.